Search research articles
Contact Us
Filters
Showing results (21-30 of 117) with videos related to
Page
of 12
Sort By:
Pharmacological Research
|
August 16, 2019
Biologics in Sjögren's syndrome
Charalampos Skarlis, Nikolaos Marketos, Clio P Mavragani
Medicine
|
June 24, 2016
Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use
Sofia Fragkioudaki, Clio P Mavragani, Haralampos M Moutsopoulos
Mediterranean Journal of Rheumatology
|
February 7, 2022
Polyarthritis and Psoriasiform Skin Lesions following Pembrolizumab Therapy
Vasiliki Koulouri, Michalis V Karamouzis, Clio P Mavragani
Journal of Autoimmunity
|
August 25, 2019
Genetic contributors and soluble mediators in prediction of autoimmune comorbidity
Adrianos Nezos, Maria-Eleutheria Evangelopoulos, Clio P Mavragani
International Journal of Inflammation
|
July 14, 2012
Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies
Clio P Mavragani, Evangelos G Spyridakis, Michael Koutsilieris
Current Opinion in Rheumatology
|
July 13, 2013
New advances in the classification, pathogenesis and treatment of Sjogren's syndrome
Clio P Mavragani, Adrianos Nezos, Haralampos M Moutsopoulos
Current Opinion in Immunology
|
December 6, 2025
Interferons in Sjogren's disease: current status and future prospects
Sylvia Raftopoulou, Athanasios-Dimitrios Bakasis, Clio P Mavragani
Current Opinion in Rheumatology
|
October 12, 2025
Advances in the diagnosis and treatment of Sjögren disease
Christos Tsironis, Asimina I Karampela, Clio P Mavragani
Clinical and Experimental Rheumatology
|
August 4, 2019
Type I interferon signature in Sjögren's syndrome: pathophysiological and clinical implications
Nikolaos Marketos, Ilir Cinoku, Anna Rapti, et al.
European Journal of Clinical Investigation
|
December 24, 2019
Atherosclerosis: Beyond the lipid storage hypothesis. The role of autoimmunity
Ilir I Cinoku, Clio P Mavragani, Haralampos M Moutsopoulos
Page
of 12
Search research articles
Search
Showing results (21-30 of 117) with videos related to
Sort By:
Page
of 12
Pharmacological Research
|
August 16, 2019
Biologics in Sjögren's syndrome
Charalampos Skarlis, Nikolaos Marketos, Clio P Mavragani
Medicine
|
June 24, 2016
Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use
Sofia Fragkioudaki, Clio P Mavragani, Haralampos M Moutsopoulos
Mediterranean Journal of Rheumatology
|
February 7, 2022
Polyarthritis and Psoriasiform Skin Lesions following Pembrolizumab Therapy
Vasiliki Koulouri, Michalis V Karamouzis, Clio P Mavragani
Journal of Autoimmunity
|
August 25, 2019
Genetic contributors and soluble mediators in prediction of autoimmune comorbidity
Adrianos Nezos, Maria-Eleutheria Evangelopoulos, Clio P Mavragani
International Journal of Inflammation
|
July 14, 2012
Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies
Clio P Mavragani, Evangelos G Spyridakis, Michael Koutsilieris
Current Opinion in Rheumatology
|
July 13, 2013
New advances in the classification, pathogenesis and treatment of Sjogren's syndrome
Clio P Mavragani, Adrianos Nezos, Haralampos M Moutsopoulos
Current Opinion in Immunology
|
December 6, 2025
Interferons in Sjogren's disease: current status and future prospects
Sylvia Raftopoulou, Athanasios-Dimitrios Bakasis, Clio P Mavragani
Current Opinion in Rheumatology
|
October 12, 2025
Advances in the diagnosis and treatment of Sjögren disease
Christos Tsironis, Asimina I Karampela, Clio P Mavragani
Clinical and Experimental Rheumatology
|
August 4, 2019
Type I interferon signature in Sjögren's syndrome: pathophysiological and clinical implications
Nikolaos Marketos, Ilir Cinoku, Anna Rapti, et al.
European Journal of Clinical Investigation
|
December 24, 2019
Atherosclerosis: Beyond the lipid storage hypothesis. The role of autoimmunity
Ilir I Cinoku, Clio P Mavragani, Haralampos M Moutsopoulos
Page
of 12